| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA12 SMCHD1 SMC2 DDX55 BLM KIF3B MDN1 MOV10L1 NAV2 MTREX DNAH5 ATP2B1 YME1L1 ATP2B2 ATP2B4 | 7.76e-06 | 441 | 174 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA12 MYO10 SMCHD1 ACTC1 SMC2 DDX55 BLM KIF3B MDN1 MOV10L1 NAV2 MTREX DNAH5 ATP2B1 YME1L1 ATP2B2 ATP2B4 | 2.76e-05 | 614 | 174 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.02e-04 | 11 | 174 | 3 | GO:0005388 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.93e-04 | 230 | 174 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 2.40e-04 | 187 | 174 | 8 | GO:0016922 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.64e-04 | 151 | 174 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | apolipoprotein A-I receptor binding | 4.48e-04 | 4 | 174 | 2 | GO:0034191 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 6.83e-04 | 46 | 174 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | NAD transmembrane transporter activity | 7.42e-04 | 5 | 174 | 2 | GO:0051724 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1E CACNA1S KCNH8 TRPA1 MRS2 CACHD1 KCNH4 SCN2A SCN9A ATP2B1 ATP2B2 ATP2B4 | 8.04e-04 | 465 | 174 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 1.01e-03 | 23 | 174 | 3 | GO:0046965 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA12 SMCHD1 SMC2 DDX55 RGS1 BLM KIF3B MDN1 MOV10L1 NAV2 MTREX DNAH5 ATP2B1 YME1L1 ATP2B2 ATP2B4 DCP1A | 1.09e-03 | 839 | 174 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA12 SMCHD1 SMC2 DDX55 RGS1 BLM KIF3B MDN1 MOV10L1 NAV2 MTREX DNAH5 ATP2B1 YME1L1 ATP2B2 ATP2B4 DCP1A | 1.10e-03 | 840 | 174 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA12 SMCHD1 SMC2 DDX55 RGS1 BLM KIF3B MDN1 MOV10L1 NAV2 MTREX DNAH5 ATP2B1 YME1L1 ATP2B2 ATP2B4 DCP1A | 1.10e-03 | 840 | 174 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.10e-03 | 182 | 174 | 7 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.17e-03 | 184 | 174 | 7 | GO:0022832 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1E CACNA1S KCNH8 TRPA1 MRS2 GRIA4 CACHD1 KCNH4 SCN2A SCN9A SLC45A2 ATP2B1 ATP2B2 ATP2B4 | 1.22e-03 | 627 | 174 | 14 | GO:0022890 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA12 SMCHD1 SMC2 DDX55 RGS1 BLM KIF3B MDN1 MOV10L1 NAV2 MTREX DNAH5 ATP2B1 YME1L1 ATP2B2 ATP2B4 | 1.26e-03 | 775 | 174 | 16 | GO:0017111 |
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.46e-03 | 26 | 174 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | apolipoprotein receptor binding | 1.54e-03 | 7 | 174 | 2 | GO:0034190 | |
| GeneOntologyMolecularFunction | protein domain specific binding | NCOA3 SCAMP1 ZNF521 SHC4 TACC2 CNTROB CHMP2A ELMO3 CCDC88A TJP1 SCN2A RNF41 PRKDC IL1B ATP2B1 ATP2B2 ATP2B4 | 1.70e-03 | 875 | 174 | 17 | GO:0019904 |
| GeneOntologyBiologicalProcess | mesenchyme migration | 5.73e-06 | 5 | 173 | 3 | GO:0090131 | |
| GeneOntologyCellularComponent | presynaptic membrane | CACNA1E GRIA4 NRXN3 SCN2A ITSN2 UNC13C ATP2B1 ATP2B2 ATP2B4 CNTN1 | 1.31e-04 | 277 | 177 | 10 | GO:0042734 |
| GeneOntologyCellularComponent | dendritic spine membrane | 4.44e-04 | 18 | 177 | 3 | GO:0032591 | |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1E SHC4 GRIA4 NRXN3 NETO1 ATP6AP2 SCN2A ITSN2 LRP1 UNC13C ATP2B1 ATP2B2 ATP2B4 CNTN1 | 4.60e-04 | 583 | 177 | 14 | GO:0097060 |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 5.27e-04 | 78 | 177 | 5 | GO:0048787 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 6.14e-04 | 46 | 177 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | cilium | NPHP1 CEP104 KIAA0586 ACTA2 TULP3 CC2D2B CCDC88A KIF3B WDR11 PKM C2CD6 FAM149B1 AGBL2 CPLANE1 DNAH5 ATP2B2 ATP2B4 PHLPP2 | 6.34e-04 | 898 | 177 | 18 | GO:0005929 |
| GeneOntologyCellularComponent | smooth muscle contractile fiber | 7.01e-04 | 5 | 177 | 2 | GO:0030485 | |
| Domain | ATP_Ca_trans_C | 3.05e-06 | 4 | 172 | 3 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 3.05e-06 | 4 | 172 | 3 | PF12424 | |
| Domain | P-type_ATPase_IIB | 3.05e-06 | 4 | 172 | 3 | IPR006408 | |
| Domain | ACTINS_1 | 4.15e-05 | 8 | 172 | 3 | PS00406 | |
| Domain | ATP2B1/4 | 8.43e-05 | 2 | 172 | 2 | IPR030319 | |
| Domain | Ion_trans_dom | 8.94e-05 | 114 | 172 | 7 | IPR005821 | |
| Domain | Ion_trans | 8.94e-05 | 114 | 172 | 7 | PF00520 | |
| Domain | DUF1518 | 2.51e-04 | 3 | 172 | 2 | PF07469 | |
| Domain | Nuc_rcpt_coact_Ncoa-typ | 2.51e-04 | 3 | 172 | 2 | IPR014920 | |
| Domain | SRC-1 | 2.51e-04 | 3 | 172 | 2 | IPR014935 | |
| Domain | Src1_rcpt_coact | 2.51e-04 | 3 | 172 | 2 | IPR008955 | |
| Domain | Nuclear_rcpt_coactivator | 2.51e-04 | 3 | 172 | 2 | IPR017426 | |
| Domain | - | 2.51e-04 | 3 | 172 | 2 | 4.10.630.10 | |
| Domain | K_chnl_volt-dep_ELK | 2.51e-04 | 3 | 172 | 2 | IPR003950 | |
| Domain | DUF1518 | 2.51e-04 | 3 | 172 | 2 | IPR010011 | |
| Domain | DUF1518 | 2.51e-04 | 3 | 172 | 2 | SM01151 | |
| Domain | SRC-1 | 2.51e-04 | 3 | 172 | 2 | PF08832 | |
| Domain | Nuc_rec_co-act | 2.51e-04 | 3 | 172 | 2 | PF08815 | |
| Domain | PAS | 2.60e-04 | 34 | 172 | 4 | PS50112 | |
| Domain | PAS | 2.60e-04 | 34 | 172 | 4 | IPR000014 | |
| Domain | ATPase_P-typ_TM_dom | 3.94e-04 | 16 | 172 | 3 | IPR023298 | |
| Domain | - | 3.94e-04 | 16 | 172 | 3 | 1.20.1110.10 | |
| Domain | Actin_CS | 3.94e-04 | 16 | 172 | 3 | IPR004001 | |
| Domain | ATPase_P-typ_cation-transptr_C | 4.75e-04 | 17 | 172 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 4.75e-04 | 17 | 172 | 3 | PF00689 | |
| Domain | ACTINS_2 | 4.75e-04 | 17 | 172 | 3 | PS00432 | |
| Domain | Cation_ATPase_N | 5.66e-04 | 18 | 172 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 5.66e-04 | 18 | 172 | 3 | SM00831 | |
| Domain | Actin/actin-like_CS | 5.66e-04 | 18 | 172 | 3 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 6.67e-04 | 19 | 172 | 3 | PS01132 | |
| Domain | ATPase_P-typ_cation-transptr_N | 6.67e-04 | 19 | 172 | 3 | IPR004014 | |
| Domain | HEAT | 9.85e-04 | 48 | 172 | 4 | PF02985 | |
| Domain | Nuc_rcpt_coact | 1.23e-03 | 6 | 172 | 2 | IPR009110 | |
| Domain | Na_trans_cytopl | 1.23e-03 | 6 | 172 | 2 | PF11933 | |
| Domain | SMC_hinge | 1.23e-03 | 6 | 172 | 2 | SM00968 | |
| Domain | Na_trans_cytopl | 1.23e-03 | 6 | 172 | 2 | IPR024583 | |
| Domain | SMC_hinge | 1.23e-03 | 6 | 172 | 2 | PF06470 | |
| Domain | SMC_hinge | 1.23e-03 | 6 | 172 | 2 | IPR010935 | |
| Domain | Ca_chan_IQ | 1.72e-03 | 7 | 172 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 1.72e-03 | 7 | 172 | 2 | PF08763 | |
| Domain | Yip1 | 1.72e-03 | 7 | 172 | 2 | IPR006977 | |
| Domain | VDCC_a1su_IQ | 1.72e-03 | 7 | 172 | 2 | IPR014873 | |
| Domain | GPHH | 1.72e-03 | 7 | 172 | 2 | PF16905 | |
| Domain | Yip1 | 1.72e-03 | 7 | 172 | 2 | PF04893 | |
| Domain | GPHH_dom | 1.72e-03 | 7 | 172 | 2 | IPR031649 | |
| Domain | Channel_four-helix_dom | 1.88e-03 | 57 | 172 | 4 | IPR027359 | |
| Domain | - | 1.88e-03 | 57 | 172 | 4 | 1.20.120.350 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 1.68e-05 | 6 | 135 | 3 | MM15663 | |
| Pubmed | CEP104 USP34 SMCHD1 DLGAP5 SNRK CACHD1 LRRK1 DDX55 KLHL9 CCDC88A NRXN3 HS2ST1 NAV2 FAM149B1 MTREX | 1.09e-07 | 529 | 178 | 15 | 14621295 | |
| Pubmed | CACNA1E NCOA3 FOXP2 CLASP1 DLGAP5 GRIA4 TSC1 SMC2 EMSY LRIG2 NCOR2 CCDC88A KIF3B MDN1 NETO1 TJP1 DIAPH2 LRP1 ATP2B4 CNTN1 | 1.30e-07 | 963 | 178 | 20 | 28671696 | |
| Pubmed | Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization. | 1.32e-07 | 3 | 178 | 3 | 7780165 | |
| Pubmed | 1.36e-07 | 10 | 178 | 4 | 1907279 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.51e-07 | 123 | 178 | 8 | 26912792 | |
| Pubmed | Transcription factor FOXP2 is a flow-induced regulator of collecting lymphatic vessels. | 3.18e-07 | 12 | 178 | 4 | 33934370 | |
| Pubmed | Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. | 4.57e-07 | 13 | 178 | 4 | 18400219 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ARID3A FOXP2 RBBP5 BCAS3 PARG CDK11A RCC1 DEPDC1 SMC2 EMSY BLM NCOR2 MDN1 PKM LRP1 UTP20 ATP2B1 DCP1A | 4.87e-07 | 857 | 178 | 18 | 25609649 |
| Pubmed | Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. | 5.25e-07 | 4 | 178 | 3 | 12209837 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 23413890 | ||
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 5.25e-07 | 4 | 178 | 3 | 8245032 | |
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 5.25e-07 | 4 | 178 | 3 | 7989379 | |
| Pubmed | PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†. | 5.25e-07 | 4 | 178 | 3 | 36130203 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 10577388 | ||
| Pubmed | Structural organization, ion transport, and energy transduction of P-type ATPases. | 5.25e-07 | 4 | 178 | 3 | 8634322 | |
| Pubmed | Nuclear receptor coregulator SNP discovery and impact on breast cancer risk. | 5.25e-07 | 4 | 178 | 3 | 20003447 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 12784250 | ||
| Pubmed | Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. | 5.25e-07 | 4 | 178 | 3 | 11152753 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 36674959 | ||
| Pubmed | Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse. | 5.25e-07 | 4 | 178 | 3 | 10434059 | |
| Pubmed | 5.25e-07 | 4 | 178 | 3 | 15101689 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | POLR1A NT5C3A ACTA1 ACTA2 ACTC1 PSMD1 HMGCR SMC2 CDKAL1 CEPT1 KLHL9 MDN1 WDR11 KLHL13 SF3B6 PKM MTR SFXN2 PRKDC TFB2M SNRPD3 YME1L1 | 5.45e-07 | 1257 | 178 | 22 | 37317656 |
| Pubmed | CACNA1E POLR1A MRS2 YIPF4 CYP21A2 ACTA2 UTP23 SNRK PPCS DCT CHMP2A SLC25A51 F13A1 BLM MDN1 KLHL13 SCN2A MOV10L1 RNF41 OSMR SNRPD3 DCP1A | 8.70e-07 | 1293 | 178 | 22 | 15342556 | |
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 10803578 | ||
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 17938178 | ||
| Pubmed | 1.31e-06 | 5 | 178 | 3 | 10757795 | ||
| Pubmed | USP34 POLR1A CLASP1 ICE2 DLGAP5 SHC4 TSC1 HMGCR DENND4C CDKAL1 KLHL9 CCDC88A TJP1 MTR YIPF3 DCP1A | 1.32e-06 | 733 | 178 | 16 | 34672954 | |
| Pubmed | CEP104 CACNA1E SMCHD1 ACTA1 ACTA2 ASH1L ACTC1 PSMD1 GRIA4 RCC1 TSC1 SMC2 DDX55 NRXN3 MDN1 TJP1 ITSN2 SCN9A PKM NAV2 PRKDC ATP2B1 ATP2B2 | 1.44e-06 | 1442 | 178 | 23 | 35575683 | |
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 12763866 | ||
| Pubmed | Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange. | 2.61e-06 | 6 | 178 | 3 | 12767889 | |
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 2.61e-06 | 6 | 178 | 3 | 22989508 | |
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 2.61e-06 | 6 | 178 | 3 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 2.61e-06 | 6 | 178 | 3 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 2.61e-06 | 6 | 178 | 3 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 2.61e-06 | 6 | 178 | 3 | 8661406 | |
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 23017337 | ||
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 9841925 | ||
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 2.61e-06 | 6 | 178 | 3 | 9971772 | |
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 2.61e-06 | 6 | 178 | 3 | 10074138 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 2.61e-06 | 6 | 178 | 3 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 2.61e-06 | 6 | 178 | 3 | 11709093 | |
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 10049817 | ||
| Pubmed | 2.61e-06 | 6 | 178 | 3 | 16881058 | ||
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 2.61e-06 | 6 | 178 | 3 | 23875777 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA3 CLASP1 PARG DLGAP5 CDK11A PSMD1 RCC1 EMSY SCAF4 BLM MED24 NCOR2 MDN1 UTP20 PRKDC DCP1A | 2.66e-06 | 774 | 178 | 16 | 15302935 |
| Pubmed | FOXP2 ABCA12 SMCHD1 ACTA1 ACTA2 ACTC1 EMSY CCDC88A ATP6AP2 PKM PRKDC OSMR SNRPD3 | 2.73e-06 | 513 | 178 | 13 | 25798074 | |
| Pubmed | Integrative predictive model of coronary artery calcification in atherosclerosis. | 3.05e-06 | 229 | 178 | 9 | 19948975 | |
| Pubmed | DLL4 promotes continuous adult intestinal lacteal regeneration and dietary fat transport. | 3.71e-06 | 21 | 178 | 4 | 26529256 | |
| Pubmed | NCOA3 ARID3A CLASP1 LCORL SMCHD1 RCC1 SMC2 DDX55 TDP2 EMSY SCAF4 MED24 NCOR2 SF3B6 PKM NCOA1 PRKDC MTREX SNRPD3 | 4.29e-06 | 1103 | 178 | 19 | 34189442 | |
| Pubmed | 4.54e-06 | 7 | 178 | 3 | 12665583 | ||
| Pubmed | 4.54e-06 | 7 | 178 | 3 | 22535526 | ||
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 4.54e-06 | 7 | 178 | 3 | 17504171 | |
| Pubmed | CD146 coordinates brain endothelial cell-pericyte communication for blood-brain barrier development. | 4.54e-06 | 7 | 178 | 3 | 28827364 | |
| Pubmed | Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice. | 4.54e-06 | 7 | 178 | 3 | 18514180 | |
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 4.54e-06 | 7 | 178 | 3 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 4.54e-06 | 7 | 178 | 3 | 22640593 | |
| Pubmed | Temporal formation of distinct thyroid hormone receptor coactivator complexes in HeLa cells. | 4.54e-06 | 7 | 178 | 3 | 11117530 | |
| Pubmed | 4.54e-06 | 7 | 178 | 3 | 22465675 | ||
| Pubmed | Developmental SMAD6 loss leads to blood vessel hemorrhage and disrupted endothelial cell junctions. | 4.54e-06 | 7 | 178 | 3 | 30098998 | |
| Pubmed | Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. | 4.54e-06 | 7 | 178 | 3 | 9384381 | |
| Pubmed | 4.54e-06 | 7 | 178 | 3 | 30289203 | ||
| Pubmed | Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation. | 4.54e-06 | 7 | 178 | 3 | 23741013 | |
| Pubmed | EMILIN1/α9β1 integrin interaction is crucial in lymphatic valve formation and maintenance. | 4.54e-06 | 7 | 178 | 3 | 24019067 | |
| Pubmed | 5.44e-06 | 23 | 178 | 4 | 9225980 | ||
| Pubmed | 5.44e-06 | 23 | 178 | 4 | 28923684 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | POLR1A SMCHD1 DLGAP5 PSMD1 RCC1 TSC1 SMC2 BLM NCOR2 MDN1 WDR11 SF3B6 PKM UTP20 PRKDC TAF2 MTREX SNRPD3 ATP2B1 YME1L1 DCP1A | 6.52e-06 | 1353 | 178 | 21 | 29467282 |
| Pubmed | The ShcA phosphotyrosine docking protein sensitizes cardiovascular signaling in the mouse embryo. | 7.24e-06 | 8 | 178 | 3 | 10809671 | |
| Pubmed | 7.24e-06 | 8 | 178 | 3 | 20147394 | ||
| Pubmed | 7.24e-06 | 8 | 178 | 3 | 16331648 | ||
| Pubmed | 7.24e-06 | 8 | 178 | 3 | 23178929 | ||
| Pubmed | 7.24e-06 | 8 | 178 | 3 | 23260110 | ||
| Pubmed | 7.24e-06 | 8 | 178 | 3 | 25377550 | ||
| Pubmed | 7.24e-06 | 8 | 178 | 3 | 20096780 | ||
| Pubmed | 7.24e-06 | 8 | 178 | 3 | 14694110 | ||
| Pubmed | 7.24e-06 | 8 | 178 | 3 | 10951186 | ||
| Pubmed | 7.24e-06 | 8 | 178 | 3 | 17475621 | ||
| Pubmed | Temporally compartmentalized expression of ephrin-B2 during renal glomerular development. | 7.24e-06 | 8 | 178 | 3 | 11729236 | |
| Pubmed | 7.24e-06 | 8 | 178 | 3 | 20388088 | ||
| Pubmed | SCAMP1 ACTA1 PSMD1 RCC1 TSC1 CACHD1 CNTROB TULP3 BLM NCOR2 CCDC88A WDR11 TJP1 ATP2B1 YME1L1 ATP2B4 DCP1A PHLPP2 | 8.20e-06 | 1049 | 178 | 18 | 27880917 | |
| Pubmed | POLR1A CLASP1 RBBP5 UTP23 CDK11A DDX55 EMSY SCAF4 BLM MED24 INTS6 CEPT1 MDN1 WDR11 ATP6AP2 SF3B6 ITSN2 UTP20 TFB2M TAF2 MTREX YME1L1 | 9.12e-06 | 1497 | 178 | 22 | 31527615 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CLASP1 RBBP5 SMCHD1 PSMD1 SMC2 BLM NCOR2 INTS6 MDN1 SF3B6 PRKDC MTREX SNRPD3 | 1.06e-05 | 582 | 178 | 13 | 20467437 |
| Pubmed | 1.08e-05 | 9 | 178 | 3 | 29202929 | ||
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 1.08e-05 | 9 | 178 | 3 | 10556093 | |
| Pubmed | Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. | 1.08e-05 | 9 | 178 | 3 | 12297046 | |
| Pubmed | Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. | 1.08e-05 | 9 | 178 | 3 | 8892894 | |
| Pubmed | 1.08e-05 | 9 | 178 | 3 | 18775311 | ||
| Pubmed | Genetic dissection of tie pathway in mouse lymphatic maturation and valve development. | 1.08e-05 | 9 | 178 | 3 | 24764452 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 CLASP1 ACTC1 CDK11A TSC1 TACC2 TDP2 EMSY BLM NCOR2 CCDC88A MTR MTREX | 1.18e-05 | 588 | 178 | 13 | 38580884 |
| Pubmed | 1.23e-05 | 28 | 178 | 4 | 24880616 | ||
| Pubmed | Enhancer activation requires trans-recruitment of a mega transcription factor complex. | 1.54e-05 | 10 | 178 | 3 | 25303530 | |
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 1.54e-05 | 10 | 178 | 3 | 1991513 | |
| Pubmed | 1.54e-05 | 10 | 178 | 3 | 23575248 | ||
| Pubmed | 1.54e-05 | 10 | 178 | 3 | 32072744 | ||
| Pubmed | Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease. | 1.54e-05 | 10 | 178 | 3 | 21749862 | |
| Pubmed | 1.54e-05 | 10 | 178 | 3 | 15001550 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 2.00e-05 | 444 | 178 | 11 | 34795231 | |
| Pubmed | 2.11e-05 | 11 | 178 | 3 | 24858485 | ||
| Pubmed | 2.11e-05 | 11 | 178 | 3 | 22207710 | ||
| Pubmed | 2.11e-05 | 11 | 178 | 3 | 34247492 | ||
| Interaction | NR1I3 interactions | 3.57e-06 | 48 | 175 | 6 | int:NR1I3 | |
| Cytoband | 6p22.3-p22.1 | 8.92e-05 | 4 | 178 | 2 | 6p22.3-p22.1 | |
| GeneFamily | Actins | 4.57e-06 | 6 | 112 | 3 | 929 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.60e-05 | 25 | 112 | 4 | 775 | |
| GeneFamily | ATPases Ca2+ transporting | 1.89e-05 | 9 | 112 | 3 | 1209 | |
| GeneFamily | Yip1 domain containing | 7.83e-04 | 7 | 112 | 2 | 105 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.33e-03 | 9 | 112 | 2 | 1203 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 NCOA3 CLASP1 MYO10 SCAMP1 SMCHD1 ROR1 CDK19 PARG DLGAP5 BARD1 ME2 SNX13 BLM NCOR2 MDN1 ITSN2 MTR NCOA1 UTP20 OSMR MTREX ATP2B1 ATP2B4 PHLPP2 | 6.94e-10 | 856 | 176 | 25 | M4500 |
| Coexpression | GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN | SCAMP1 KIAA0586 ASH1L PSMD1 F13A1 EMSY DENND4C SCAF4 NCOA1 RNF41 ATP2B4 | 1.13e-07 | 199 | 176 | 11 | M5799 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MYO10 ICE2 SMCHD1 DLGAP5 DEPDC1 SMC2 DCT SNX13 DMXL1 BLM CCDC88A WDR11 ITSN2 MTR SLC45A2 MTREX CPLANE1 | 2.28e-06 | 656 | 176 | 17 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NCOA3 CLASP1 MYO10 SMCHD1 PARG BARD1 SNX13 BLM MDN1 ITSN2 NCOA1 MTREX ATP2B1 PHLPP2 | 3.49e-06 | 466 | 176 | 14 | M13522 |
| Coexpression | GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_UP | 8.18e-06 | 198 | 176 | 9 | M8866 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN | 8.87e-06 | 200 | 176 | 9 | M6102 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_UP | 8.87e-06 | 200 | 176 | 9 | M6254 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.21e-05 | 208 | 176 | 9 | M39233 | |
| Coexpression | GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_UP | 4.05e-05 | 187 | 176 | 8 | M6809 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_483_5P_GENES | 4.72e-05 | 11 | 176 | 3 | MM17503 | |
| Coexpression | GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_DN | 6.50e-05 | 200 | 176 | 8 | M5274 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 6.50e-05 | 200 | 176 | 8 | M5915 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | CHCHD7 SMCHD1 CDK19 DLGAP5 TACC2 ME2 DMXL1 DIAPH2 PKM LRP1 MTR SLC45A2 PRKDC TAF2 QDPR ATP2B1 | 9.07e-05 | 790 | 176 | 16 | M12490 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.44e-05 | 110 | 174 | 7 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | BCAS3 ICE2 PECAM1 PARG KIAA0586 BARD1 TSC1 ME2 TDP2 BLM SETDB2 MDN1 TAF9B MOV10L1 MTR UTP20 PRKDC MTREX CPLANE1 | 3.86e-05 | 810 | 174 | 19 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_200 | 6.38e-05 | 164 | 174 | 8 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#3_top-relative-expression-ranked_200 | 8.63e-05 | 88 | 174 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | NCOA3 YIPF4 KIAA0586 ASH1L SMC2 CDKAL1 NAV2 SFXN2 ATP2B1 YME1L1 | 1.00e-04 | 277 | 174 | 10 | gudmap_developingGonad_e12.5_ovary_k3_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | NCOA3 POLR1A LCORL ACTA1 ACTA2 ASH1L SMC2 DMXL1 SULT1E1 DIAPH2 LRP1 NAV2 SFXN2 UNC13C OSMR CPLANE1 PZP ATP2B1 | 1.01e-04 | 797 | 174 | 18 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | NCOA3 CLASP1 LCORL ACTA2 ASH1L TSC1 SMC2 F13A1 CDKAL1 DMXL1 SULT1E1 DIAPH2 LRP1 NAV2 SFXN2 CPLANE1 ATP2B1 YME1L1 | 1.04e-04 | 799 | 174 | 18 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | NCOA3 CLASP1 LCORL YIPF4 SMCHD1 KIAA0586 ASH1L TSC1 SMC2 DCT CDKAL1 DMXL1 KLHL13 NAV2 SFXN2 CPLANE1 ATP2B1 YME1L1 | 1.12e-04 | 804 | 174 | 18 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | NCOA3 POLR1A CLASP1 LCORL MYO10 KIAA0586 ASH1L SMC2 DCT CDKAL1 DMXL1 MOV10L1 NAV2 MTR SFXN2 CPLANE1 ATP2B1 YME1L1 | 1.16e-04 | 806 | 174 | 18 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_500 | 1.85e-04 | 101 | 174 | 6 | gudmap_developingGonad_e14.5_ ovary_500_k1 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-08 | 169 | 177 | 9 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 9.57e-08 | 196 | 177 | 9 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-07 | 198 | 177 | 9 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.14e-07 | 200 | 177 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.14e-07 | 200 | 177 | 9 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-07 | 158 | 177 | 8 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-07 | 158 | 177 | 8 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.57e-07 | 187 | 177 | 8 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.92e-07 | 188 | 177 | 8 | a244fcd092d5bd544e503366b1439b0fbc1ee00e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.92e-07 | 188 | 177 | 8 | c8530c9ff98666c64a94683261af4288cb790a7e | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.05e-06 | 192 | 177 | 8 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 195 | 177 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.42e-06 | 200 | 177 | 8 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 177 | 8 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D175|Adult / Lineage, Cell type, age group and donor | 2.37e-06 | 150 | 177 | 7 | b0b6ba3686d3eb8a9b249d30be14111de3b893be | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-06 | 167 | 177 | 7 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | severe-HSPC|World / disease stage, cell group and cell class | 5.22e-06 | 169 | 177 | 7 | b0421b73bfdc92f7a2762b4b670b9eae124aa702 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-06 | 169 | 177 | 7 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.48e-06 | 182 | 177 | 7 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.48e-06 | 182 | 177 | 7 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 9.43e-06 | 185 | 177 | 7 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 9.77e-06 | 186 | 177 | 7 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 1.16e-05 | 191 | 177 | 7 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 1.20e-05 | 192 | 177 | 7 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-05 | 193 | 177 | 7 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | facs-Liver-Non-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 193 | 177 | 7 | 8084fa0ce61f1f4a728423b6b81df04eaa5af5b6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 193 | 177 | 7 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 193 | 177 | 7 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-05 | 193 | 177 | 7 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 193 | 177 | 7 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-05 | 194 | 177 | 7 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-05 | 194 | 177 | 7 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-05 | 194 | 177 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.33e-05 | 195 | 177 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 195 | 177 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-05 | 196 | 177 | 7 | 36ed1918f70b6f5760bb088b15ce422998055cc7 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 1.42e-05 | 197 | 177 | 7 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 197 | 177 | 7 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 197 | 177 | 7 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | mild-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.42e-05 | 197 | 177 | 7 | 0cb00daa6943f7a7fb34a8fdf51188646af65686 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 1.42e-05 | 197 | 177 | 7 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-05 | 198 | 177 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-05 | 198 | 177 | 7 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 198 | 177 | 7 | f0f1816a0ed3ae8207442602f5cbe4de0382e4b3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.51e-05 | 199 | 177 | 7 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 177 | 7 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 177 | 7 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.56e-05 | 200 | 177 | 7 | f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 177 | 7 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 149 | 177 | 6 | 48fca6ae33d7722c024b43ce04f4dbce7b6b424b | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.80e-05 | 156 | 177 | 6 | 8353f98e7d393d4299ed1da8f66cfbc7176df1b5 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.02e-05 | 164 | 177 | 6 | 0662cd9d21608efacc336e0a582859f3b9a4951d | |
| ToppCell | severe-HSPC|severe / disease stage, cell group and cell class | 5.19e-05 | 165 | 177 | 6 | acd837d88ad3786c263f74651a6c0e02fa2fa2c5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.19e-05 | 165 | 177 | 6 | a74751e0ec857aa974bec04ccc747c004a8f6e01 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 5.74e-05 | 168 | 177 | 6 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 5.74e-05 | 168 | 177 | 6 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.93e-05 | 169 | 177 | 6 | db73dae011ff3749b3706e50ab46d03b775dd6bb | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.93e-05 | 169 | 177 | 6 | 97b7047b87ce0052d8580565c9b44fd2aa6f0d5c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.93e-05 | 169 | 177 | 6 | 1a684471dbda42e1470e5a889648666e14f25982 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.93e-05 | 169 | 177 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | CV-Mild-7|CV / Virus stimulation, Condition and Cluster | 6.13e-05 | 170 | 177 | 6 | 25ebde7d2f8ae1afdfaf5876284ff20bb179eb10 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_HSPB3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.13e-05 | 170 | 177 | 6 | 985c6c9e3c593ed0628a481f06c2c91b2ab5d746 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.75e-05 | 173 | 177 | 6 | e3cb7c8c09f937da6b8d673e9adfec5d94a15548 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 6.75e-05 | 173 | 177 | 6 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.97e-05 | 174 | 177 | 6 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.97e-05 | 174 | 177 | 6 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D231|Adult / Lineage, Cell type, age group and donor | 6.97e-05 | 174 | 177 | 6 | 2dd647c4fdf99fd1f7b838efef01baf2cbc3446d | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.19e-05 | 175 | 177 | 6 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.19e-05 | 175 | 177 | 6 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.42e-05 | 176 | 177 | 6 | 1510cdfcfb46ce1196a1220c07fb5f3986c81b78 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-05 | 176 | 177 | 6 | 3494ffa8555e6edf4b1250e10434bae9b73ec845 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.42e-05 | 176 | 177 | 6 | d43f6b7828b98e1dab7b726a5f99499d65a7db80 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.15e-05 | 179 | 177 | 6 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | moderate-Myeloid-pDC|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.40e-05 | 180 | 177 | 6 | a0751ad5e42a21cb107d900abfa9ee967a0069fc | |
| ToppCell | NS-moderate-d_16-33-Myeloid-pDC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.40e-05 | 180 | 177 | 6 | 144818e69613296cde43f29cb8c20899c670b319 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 8.40e-05 | 180 | 177 | 6 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 8.66e-05 | 181 | 177 | 6 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 8.66e-05 | 181 | 177 | 6 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.93e-05 | 182 | 177 | 6 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.93e-05 | 182 | 177 | 6 | ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.20e-05 | 183 | 177 | 6 | 29b62dd542bc3f8df843998f577724f3818d4271 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.48e-05 | 184 | 177 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.48e-05 | 184 | 177 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.48e-05 | 184 | 177 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 9.48e-05 | 184 | 177 | 6 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.76e-05 | 185 | 177 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.76e-05 | 185 | 177 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.00e-04 | 116 | 177 | 5 | df7609503782d8d7e4f31ed2a626916e5474d5bc | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 177 | 6 | 37860daeecd6d412bd3797f30496a56da667fbd1 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.01e-04 | 186 | 177 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 177 | 6 | 60830822d3de3147816693404fd03392e04c2b8e | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 177 | 6 | baebeffdd426ce767190ddefc857cc78e6a58d36 | |
| ToppCell | COVID_vent-Myeloid-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.01e-04 | 186 | 177 | 6 | 63a5cdd3f60681762a218be32db84be8f29b88fd | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 186 | 177 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.01e-04 | 186 | 177 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | COVID_vent-Myeloid-Dendritic-cDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.01e-04 | 186 | 177 | 6 | 39457a7b43537f2c3e221f9375c95d4515424d7d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-04 | 187 | 177 | 6 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 187 | 177 | 6 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 187 | 177 | 6 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 187 | 177 | 6 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| Drug | clioquinol | 2.86e-07 | 114 | 178 | 9 | CID000002788 | |
| Drug | caged ATP | 1.26e-06 | 70 | 178 | 7 | CID000123806 | |
| Drug | NSC3260 | MYO10 ACTA1 ACTA2 ACTC1 GRIA4 PKM ATP2B1 ATP2B2 ATP2B4 ALOX15 | 3.30e-06 | 195 | 178 | 10 | CID000220461 |
| Drug | CaCl2 | 3.97e-06 | 156 | 178 | 9 | CID000024854 | |
| Drug | Acyclovir [59277-89-3]; Up 200; 17.8uM; HL60; HG-U133A | RBBP5 YIPF4 LRRK1 CDKAL1 SCAF4 HS2ST1 ITSN2 NCOA1 ATP2B1 CNTN1 | 4.14e-06 | 200 | 178 | 10 | 2044_UP |
| Drug | manidipine | 9.82e-06 | 95 | 178 | 7 | CID000004008 | |
| Drug | mag-fura-2 | 9.83e-06 | 37 | 178 | 5 | CID000123839 | |
| Drug | Isoflupredone acetate [338-98-7]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.79e-05 | 188 | 178 | 9 | 1832_UP | |
| Drug | Bay K 8644 | 2.44e-05 | 150 | 178 | 8 | CID000002303 | |
| Drug | Azathioprine [446-86-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 2.59e-05 | 197 | 178 | 9 | 1528_UP | |
| Drug | Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; HL60; HG-U133A | 2.70e-05 | 198 | 178 | 9 | 1438_DN | |
| Disease | JOUBERT SYNDROME 17 | 2.10e-06 | 5 | 177 | 3 | C3553264 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 4.19e-06 | 6 | 177 | 3 | DOID:0050429 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | USP34 FOXP2 LCORL CHCHD7 RBBP5 YIPF4 CYP21A2 ROR1 CRPPA HMGCR CACHD1 ACKR4 CDKAL1 SNX13 TG CCDC88A ANGPTL2 TJP1 TOX3 RASGEF1C NAV2 FGD6 PDZD2 | 6.21e-06 | 1345 | 177 | 23 | EFO_0010736 |
| Disease | Moyamoya disease (implicated_via_orthology) | 1.16e-05 | 8 | 177 | 3 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 1.16e-05 | 8 | 177 | 3 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 1.16e-05 | 8 | 177 | 3 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 1.16e-05 | 8 | 177 | 3 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 2.47e-05 | 10 | 177 | 3 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 2.47e-05 | 10 | 177 | 3 | DOID:13832 (implicated_via_orthology) | |
| Disease | Familial aplasia of the vermis | 3.04e-05 | 30 | 177 | 4 | C0431399 | |
| Disease | keratoconjunctivitis (is_marker_for) | 1.07e-04 | 3 | 177 | 2 | DOID:9368 (is_marker_for) | |
| Disease | facial asymmetry measurement | 1.92e-04 | 19 | 177 | 3 | EFO_0009751 | |
| Disease | dry eye syndrome (is_implicated_in) | 2.13e-04 | 4 | 177 | 2 | DOID:10140 (is_implicated_in) | |
| Disease | Joubert syndrome 1 | 2.61e-04 | 21 | 177 | 3 | C4551568 | |
| Disease | oculocutaneous albinism (implicated_via_orthology) | 3.54e-04 | 5 | 177 | 2 | DOID:0050632 (implicated_via_orthology) | |
| Disease | myeloperoxidase measurement | 4.98e-04 | 26 | 177 | 3 | EFO_0005243 | |
| Disease | OROFACIODIGITAL SYNDROME VI | 7.37e-04 | 7 | 177 | 2 | C2745997 | |
| Disease | Myopathy | 7.65e-04 | 30 | 177 | 3 | C0026848 | |
| Disease | spontaneous coronary artery dissection | 8.43e-04 | 31 | 177 | 3 | EFO_0010820 | |
| Disease | Squamous cell carcinoma | 9.29e-04 | 124 | 177 | 5 | C0007137 | |
| Disease | Myopathies, Nemaline | 9.78e-04 | 8 | 177 | 2 | C0206157 | |
| Disease | behavioural disinhibition measurement | 1.09e-03 | 75 | 177 | 4 | EFO_0006946 | |
| Disease | cortical thickness | FBXW10 FOXP2 CHCHD7 ROR1 TACC2 ME2 PXK TG CCDC88A TOX3 RASGEF1C LRP1 NAV2 OSMR AGBL2 PDZD2 | 1.14e-03 | 1113 | 177 | 16 | EFO_0004840 |
| Disease | creatinine measurement, chronic kidney disease | 1.21e-03 | 35 | 177 | 3 | EFO_0003884, EFO_0004518 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 1.25e-03 | 9 | 177 | 2 | C3502809 | |
| Disease | hair colour measurement | SHC4 BPIFB6 DCT RGS1 CDKAL1 SNX13 ANGPTL2 TOX3 LRP1 SLC45A2 UNC13C | 1.28e-03 | 615 | 177 | 11 | EFO_0007822 |
| Disease | Mammary Carcinoma, Human | 1.33e-03 | 525 | 177 | 10 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.33e-03 | 525 | 177 | 10 | C1257931 | |
| Disease | Mammary Neoplasms | 1.37e-03 | 527 | 177 | 10 | C1458155 | |
| Disease | urea measurement | 1.56e-03 | 10 | 177 | 2 | EFO_0011005 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.56e-03 | 10 | 177 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.56e-03 | 10 | 177 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | cholesteatoma (is_marker_for) | 1.56e-03 | 10 | 177 | 2 | DOID:869 (is_marker_for) | |
| Disease | obsolete_9,10-dihome measurement | 1.56e-03 | 10 | 177 | 2 | EFO_0021572 | |
| Disease | dry eye syndrome (is_marker_for) | 1.56e-03 | 10 | 177 | 2 | DOID:10140 (is_marker_for) | |
| Disease | Breast Carcinoma | 1.60e-03 | 538 | 177 | 10 | C0678222 | |
| Disease | ciliopathy (implicated_via_orthology) | 1.78e-03 | 40 | 177 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | fat body mass | 2.04e-03 | 217 | 177 | 6 | EFO_0005409 | |
| Disease | neuroimaging measurement | FOXP2 LCORL CHCHD7 RBBP5 CYP21A2 ROR1 ZNF521 PSMD1 TACC2 DENND4C TG CCDC88A TOX3 NAV2 FGD6 | 2.05e-03 | 1069 | 177 | 15 | EFO_0004346 |
| Disease | Autoimmune Diseases | 2.05e-03 | 42 | 177 | 3 | C0004364 | |
| Disease | Malignant neoplasm of breast | NCOA3 ROR1 ACTA2 BARD1 TACC2 ITGA9 SLC25A51 EMSY NLRP9 ITSN2 TOX3 MTR NCOA1 UTP20 IL1B | 2.14e-03 | 1074 | 177 | 15 | C0006142 |
| Disease | response to methotrexate, serum alanine aminotransferase measurement | 2.20e-03 | 43 | 177 | 3 | EFO_0004735, GO_0031427 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.27e-03 | 12 | 177 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | beta wave measurement | 2.27e-03 | 12 | 177 | 2 | EFO_0006871 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.28e-03 | 152 | 177 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | hypertension (biomarker_via_orthology) | 2.56e-03 | 227 | 177 | 6 | DOID:10763 (biomarker_via_orthology) | |
| Disease | HbA1c measurement | CEP104 CLASP1 LCORL CDK19 ASH1L ZKSCAN5 CDKAL1 HROB SF3B6 ATP2B4 MAP4K2 | 2.64e-03 | 675 | 177 | 11 | EFO_0004541 |
| Disease | rhinitis (is_marker_for) | 2.67e-03 | 46 | 177 | 3 | DOID:4483 (is_marker_for) | |
| Disease | Infantile Severe Myoclonic Epilepsy | 2.67e-03 | 13 | 177 | 2 | C0751122 | |
| Disease | illegal drug consumption | 2.67e-03 | 13 | 177 | 2 | EFO_0005431 | |
| Disease | systolic blood pressure, cigarettes per day measurement | 2.67e-03 | 13 | 177 | 2 | EFO_0006335, EFO_0006525 | |
| Disease | rhinitis (biomarker_via_orthology) | 2.67e-03 | 13 | 177 | 2 | DOID:4483 (biomarker_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 3.09e-03 | 163 | 177 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Birth Weight | 3.11e-03 | 14 | 177 | 2 | C0005612 | |
| Disease | diffuse large B-cell lymphoma | 3.11e-03 | 14 | 177 | 2 | EFO_0000403 | |
| Disease | Graves' disease (is_marker_for) | 3.57e-03 | 15 | 177 | 2 | DOID:12361 (is_marker_for) | |
| Disease | posterior thigh muscle volume | 3.57e-03 | 15 | 177 | 2 | EFO_0020931 | |
| Disease | physical activity measurement | 3.72e-03 | 245 | 177 | 6 | EFO_0008002 | |
| Disease | Schizoaffective disorder-bipolar type | 4.06e-03 | 16 | 177 | 2 | EFO_0009965 | |
| Disease | Metastatic melanoma | 4.21e-03 | 54 | 177 | 3 | C0278883 | |
| Disease | corneal topography | 4.27e-03 | 109 | 177 | 4 | EFO_0004345 | |
| Disease | Ciliopathies | 4.41e-03 | 110 | 177 | 4 | C4277690 | |
| Disease | phenylalanine measurement | 4.43e-03 | 55 | 177 | 3 | EFO_0005001 | |
| Disease | Nasal Cavity Polyp | 4.43e-03 | 55 | 177 | 3 | EFO_1000391 | |
| Disease | allergic rhinitis (is_marker_for) | 4.59e-03 | 17 | 177 | 2 | DOID:4481 (is_marker_for) | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 4.59e-03 | 17 | 177 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | otitis media (biomarker_via_orthology) | 4.59e-03 | 17 | 177 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | sinusitis (is_marker_for) | 5.14e-03 | 18 | 177 | 2 | DOID:0050127 (is_marker_for) | |
| Disease | kidney volume | 5.14e-03 | 18 | 177 | 2 | EFO_0600044 | |
| Disease | Drug habituation | 5.16e-03 | 115 | 177 | 4 | C0013170 | |
| Disease | Drug abuse | 5.16e-03 | 115 | 177 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 5.16e-03 | 115 | 177 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 5.16e-03 | 115 | 177 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 5.16e-03 | 115 | 177 | 4 | C0013222 | |
| Disease | Drug Dependence | 5.16e-03 | 115 | 177 | 4 | C1510472 | |
| Disease | Substance Dependence | 5.16e-03 | 115 | 177 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 5.16e-03 | 115 | 177 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 5.16e-03 | 115 | 177 | 4 | C0029231 | |
| Disease | Substance abuse problem | 5.32e-03 | 116 | 177 | 4 | C0740858 | |
| Disease | creatinine measurement, glomerular filtration rate | 5.48e-03 | 117 | 177 | 4 | EFO_0004518, EFO_0005208 | |
| Disease | body surface area | POLR1A LCORL CHCHD7 SMCHD1 CYP21A2 NCOR2 NRXN3 PDILT ITSN2 ZNF844 | 5.64e-03 | 643 | 177 | 10 | EFO_0022196 |
| Disease | total blood protein measurement | 5.91e-03 | 449 | 177 | 8 | EFO_0004536 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MMPEFQKSSVRIKNP | 51 | Q9H0P0 | |
| MQRRKNGVKPFMPTA | 56 | Q9BUK0 | |
| QMRSPVKMKPPVLSV | 896 | Q9NR48 | |
| ANKKPMQLPRSMVKS | 116 | Q9BWU1 | |
| PSAMKLLPNMAVKRN | 411 | Q99728 | |
| LSQKMLDLLVPMPKA | 1846 | Q15878 | |
| PLNPKANREKMTQIM | 111 | P68133 | |
| MRSLKQMHLPRSVPL | 691 | Q86UK0 | |
| PLTSMQVIKPNRMLA | 941 | Q5XX13 | |
| PLNPKANREKMTQIM | 111 | P62736 | |
| LPVIKGSMMVLNQLS | 416 | Q5VU97 | |
| YSLKKVVMMIRPNPN | 476 | Q9UKU9 | |
| LMMSKLPLENPVVLN | 31 | Q16663 | |
| VARMEPPKQKLSMLI | 1576 | Q9P1Z9 | |
| PKQPNMMTEIVKILS | 266 | O60879 | |
| LPVTLDTPMNRKSMP | 181 | P09417 | |
| PSLMVVMPLAQIKQP | 521 | Q9H6U6 | |
| VMPLAQIKQPMTLGT | 526 | Q9H6U6 | |
| MMQAVKTTPRQRSPL | 341 | Q9NPI6 | |
| SSPVVNQRKLPKDMM | 176 | Q6DHV5 | |
| VTKAMGTMNRQLKLP | 106 | O43633 | |
| GTMKMRILPDQFSPL | 3001 | Q9Y485 | |
| PYGRNKPLISRTMMK | 916 | P20020 | |
| GRNKPLISRTMMKNI | 941 | Q01814 | |
| GRNKPLISRTMMKNI | 906 | P23634 | |
| MSLPQPTPRMAELRK | 1 | Q09MP3 | |
| LEPMKKSMVPVQVQL | 156 | P18754 | |
| MVSGFIPLKPTVKML | 1391 | P20742 | |
| LIPPMNRRNILVMKH | 466 | Q8TDF5 | |
| MAPKRVVQLSLKMPT | 1 | Q9ULC6 | |
| KMQMAVSLRLALPPP | 946 | Q99650 | |
| MRAAAISTPKLDKMP | 1 | Q08116 | |
| MPLSSFLLKPMQRIT | 1341 | Q9NZM3 | |
| PLKKAVRMMGAPNLI | 426 | Q9UL03 | |
| LVPPSQKMENLMQIR | 381 | A4D126 | |
| RALMLMSKSSFQPPK | 221 | Q12851 | |
| TLMKMPNIKISRPLK | 226 | Q9NPB9 | |
| KQPLLSMCPTIMVGQ | 446 | A6NGU5 | |
| EKQMRQLAVIPPMLY | 386 | Q9Y618 | |
| MDKLRKMLVPCPQTF | 71 | P01584 | |
| PPIMLLVDGKQQMVV | 31 | Q6ISU1 | |
| KMCLTFMKESPLPRL | 4066 | Q9NU22 | |
| PMQLGPVIKSRLAMA | 916 | Q9BXT6 | |
| CKLMKMIIVGPPRQG | 636 | Q38SD2 | |
| ENKPNPVTQRVKMIM | 246 | P04035 | |
| SNMKLLRVDIPQQPM | 2451 | Q07954 | |
| PNIPLVAQELMKKMI | 151 | Q8N3X6 | |
| SMMLLRVKQSPGTKL | 66 | Q9Y6C7 | |
| ALLRMPKMPELRGKQ | 456 | Q8NHQ9 | |
| QLKPLQKITEPSMFM | 251 | Q53TS8 | |
| LKMQPFQVRLQPRGM | 471 | P08686 | |
| QLIMMSLPNVLIIGK | 96 | Q3V6T2 | |
| PFMSLGISIMIKKPQ | 516 | P48058 | |
| PIPLLKQKMNHSITM | 611 | Q86W56 | |
| LLQKPKMIARRPIMA | 1786 | O15018 | |
| KQMPVEMSRPAVPLL | 631 | P16284 | |
| ALQKMLTLLMLPPTF | 371 | O00748 | |
| KQRPLQVPVSVAMMT | 81 | O15409 | |
| PPNRRKLQLLMRMIS | 611 | Q5TB30 | |
| PMMASLPKKTLLADR | 406 | Q9HD23 | |
| PFFVRCIKPNMQKMP | 631 | Q9HD67 | |
| PPIFNSVMARTKMKR | 556 | Q8NG66 | |
| LMKNIRFPLMTPQDL | 236 | Q9P2J3 | |
| MPVMKGLLAPQNTFL | 1 | Q9UQ05 | |
| VMLKLQPDGKLLPMV | 301 | P16050 | |
| PMKKMFREIRPNSTV | 676 | P00488 | |
| CATQMLESMIKKPRP | 326 | P14618 | |
| PRNKVPNMAVMIKSL | 491 | Q8N3J3 | |
| TVQMVKMQRVPGPKD | 1111 | Q6ZVL6 | |
| PTMQLFMQLAPKLRG | 551 | P98088 | |
| LTPMLNPMIYSLRNK | 281 | Q13607 | |
| PMLNPMIYSLRNKDV | 281 | Q8NGP4 | |
| NKVLVCPMKSAPVML | 121 | Q15291 | |
| GPLQITMKMVPKLLS | 201 | Q9HAB8 | |
| SMKLSGQKINPVLRM | 411 | Q13797 | |
| VMVMVKGVNKLALPP | 76 | O75787 | |
| QSMIPVLNIQMKIFP | 236 | Q9Y6K0 | |
| LALSKKLMEMPVGTP | 456 | O60308 | |
| SPLPQKKMTMRERNQ | 326 | Q659A1 | |
| AKLMKNIRFPLMTPQ | 276 | Q9P2N7 | |
| LLSKPEKMSMQELNP | 341 | P54132 | |
| MLRQKFPSVPVMALT | 816 | P54132 | |
| VMQKIRMKGSLPSLS | 1221 | Q9H799 | |
| NVKPPKMLPMLITSL | 191 | Q9HB03 | |
| MLKGLLTQRAMPRGQ | 1721 | Q13698 | |
| QVLVPKNPAFMGKMV | 461 | Q5VV42 | |
| LKILALAPTFEMNPM | 406 | Q12860 | |
| EKKVVQPVMPTSLRM | 191 | Q15398 | |
| LSQQMKPGMKRQRSL | 1831 | Q5VZ89 | |
| SMATLILPKNKGRMQ | 831 | Q5U5Z8 | |
| LKSLMETMKQPFLPG | 511 | Q9UQ88 | |
| MAPPRNVVKIAIKMR | 1 | Q96BJ8 | |
| TNLPSNMLPKMVNKF | 146 | Q8NFQ5 | |
| KPLMLNPRTNKGMAF | 26 | P23368 | |
| RFPTLVQLMQPKAMP | 6 | Q587J8 | |
| ISSKMLPMKHPLQSL | 1251 | Q9ULL0 | |
| MIVDPPKKALATSML | 1166 | Q7Z589 | |
| PLISPRQMKKQDSML | 3461 | Q8NDH2 | |
| QDKPPGMIQRKMCIL | 5416 | Q8NDH2 | |
| RPVPRIMRNMLSKLQ | 66 | Q9H4P4 | |
| LFSLMDMKPPISRAK | 11 | O95104 | |
| MTLKSLLRALVNMPP | 301 | Q9UMX9 | |
| TMPPMAVALKPVLQQ | 601 | Q8N137 | |
| VKERLQKMGPFQPMN | 4376 | Q8TE73 | |
| KMIPLPGMSIQVLSR | 391 | O15259 | |
| ISEITMPGKIFPLKM | 141 | Q9Y5E3 | |
| GMPLQPRNLSLMDKL | 361 | Q96BN6 | |
| NMLAFIPVLTKKMNP | 36 | P03891 | |
| KEVPMMRKGLPEQQS | 521 | Q8N807 | |
| PSMIGPKNILITTNM | 211 | Q9HBM6 | |
| LQLLLAPEMMKASPA | 661 | Q9Y5W8 | |
| VPLAFAMVKLMQSLP | 1821 | O75691 | |
| KKPGVPLMFIIQNTM | 131 | Q9BRU9 | |
| PLMFIIQNTMVLDKP | 136 | Q9BRU9 | |
| TPMMSVPVLNTKKAL | 1261 | O95602 | |
| LQNKAPPMDKLRGMV | 1876 | A6NHR9 | |
| AVGMNMLTKKAPPLV | 161 | Q96NB2 | |
| PPLMQKTTTLALMFG | 86 | Q9H1U9 | |
| ILNMLTKNPPFTKNM | 926 | Q6P1X5 | |
| KKSPQLLKLPIMQMR | 146 | Q7Z6M4 | |
| MVRQKPSLGTMPVQV | 1011 | Q15788 | |
| MVPKLPAGKMNNRDL | 486 | Q9HDB5 | |
| TVLKSMNLPPLGRTM | 206 | Q7RTY7 | |
| PQDQLRFPRMLMKLV | 411 | P55055 | |
| IMMPPKLQLLAVVAF | 6 | Q7LGA3 | |
| GKMFLPQVIKSARVM | 726 | Q99707 | |
| QLTMVKRMQHIPTPL | 266 | O75448 | |
| KNISAFPMLPKQPML | 871 | Q9Y6Q9 | |
| MPAILVASKMKSGLP | 1 | Q8IVL1 | |
| PARVMPAQLKVLTMP | 881 | Q99460 | |
| AKPNKVQLIAMDLPM | 1816 | Q15858 | |
| PPSPRDKLFNKSMML | 646 | Q9ULL8 | |
| VKMPNVPNTQPAIMK | 51 | O15126 | |
| MIPRQNLFTKNLTPM | 301 | Q9H5Q4 | |
| PPLMQKTTTLALMFG | 86 | Q3SY17 | |
| FLTMNQKMLKPHRTP | 406 | Q8NA69 | |
| PMLNPMIYSLRNKDV | 281 | Q8NGP3 | |
| MDENLPPKLSRLKMN | 501 | Q9NRH2 | |
| PLNPKANREKMTQIM | 111 | P68032 | |
| FMQKRGTPVNRIPIM | 251 | Q99856 | |
| MPTIFNLIPNSAKIM | 411 | Q7Z460 | |
| QPMPIILSSLLQKKM | 251 | Q7RTR0 | |
| FARSNPMILMRLKLP | 266 | Q01973 | |
| LIPRMASMKLANPAT | 86 | Q6S5L8 | |
| CLMKMPLNLKGENPL | 151 | Q96T68 | |
| PVVAMKPSLMFLAKA | 106 | Q7RTX0 | |
| LITMLPMIPQSGKQH | 136 | Q92574 | |
| IPMTILVVNIKPGMA | 731 | O75762 | |
| RMKVLELQSPPKASM | 1526 | Q8NB66 | |
| MPKLTEQLAGPLRQM | 921 | P42285 | |
| LLPMSKDRMELQKSP | 1216 | Q6ZVD8 | |
| IMNQKLSPFMRKGIT | 246 | P49888 | |
| PITRLENQQMMKRPV | 616 | O15066 | |
| IISGMNMSPVSRLKK | 301 | Q8N431 | |
| MAMQAAKRANIRLPP | 1 | Q9Y3B4 | |
| PLSPVAIEQTSLKMM | 606 | Q96K83 | |
| NMLSLAGMKVRKPTQ | 1131 | Q6ZV73 | |
| ASRVLPILPMNGKMH | 631 | Q99250 | |
| LKSQEIIPFPSTKMM | 191 | O95551 | |
| IIPFPSTKMMRNLLC | 196 | O95551 | |
| KNGMPTISRLLQMPL | 381 | Q7Z7A4 | |
| MPCLDRMPLLAKGKQ | 1326 | O95359 | |
| RSIAPKPLTMRLPMN | 381 | O15405 | |
| KPLTMRLPMNQIVTS | 386 | O15405 | |
| LILPDMLKNAPMLKS | 71 | P62318 | |
| QMGRNSMKLPTLKDI | 311 | P40126 | |
| MQGRITKVLNMKPPE | 146 | O95347 | |
| TKVLNMKPPEILSMI | 151 | O95347 | |
| PDVCVNLMKALKMSP | 1396 | P78527 | |
| PFTIMKGLTLERNPM | 406 | Q08AG5 | |
| KPLTMKRNEMIAKPS | 61 | Q68DY1 | |
| KDAMPINKATIMPRG | 611 | Q96TA2 | |
| DPAMKPQSVLTRVKM | 1256 | Q07157 | |
| SMIPIKMVNFPQKIA | 136 | Q9GZM5 | |
| MQPLSKLMAISKPRN | 1 | Q9UL58 | |
| MHRTQMLLQKLKGPP | 271 | Q9C0K7 | |
| KIRCVLMPMPSLGFN | 91 | Q9BSR8 | |
| KMPQLKPETISMTGL | 1056 | Q70CQ2 | |
| RMCPPLTTKNIKMYQ | 471 | Q9BZH6 | |
| RNKLMTLPDASLLPM | 486 | O60603 | |
| QKLMGISIRNKVPMS | 1971 | P01266 | |
| KGPRKMSVIIPGMTL | 316 | O75386 | |
| HKEPQFMLQSKPRML | 291 | Q6P2D8 | |
| SMVQPKESLSMLKLP | 436 | Q9BVV6 | |
| IPMKEILGQPSSKRM | 516 | Q9Y2L8 | |
| MPVMKGLLAPQNTFL | 1 | Q96L42 | |
| VVKLNRNRMSMIPPK | 196 | O94898 | |
| RNRMSMIPPKIFKLP | 201 | O94898 |